| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5a95d4999542f2d9fa147bfed0e90cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-650952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6509 |
| filingDate |
1994-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef9ec64dd473d22321ffc336973af7be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146443cab0a1516f785c1bfb9eab2cbd |
| publicationDate |
1996-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5500419-A |
| titleOfInvention |
NMDA antagonists |
| abstract |
The present invention is directed to a new neuroprotective agent. The agent is R-4-oxo-5-phosphononorvaline. This agent is useful in the treatment of ischemic and hypoxic conditions such as stroke. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5856505-A |
| priorityDate |
1989-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |